Freeline Therapeutics Holdings plc Quarterly Accounts Payable, Current in USD from Q4 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Freeline Therapeutics Holdings plc quarterly Accounts Payable, Current history and growth rate from Q4 2019 to Q3 2023.
  • Freeline Therapeutics Holdings plc Accounts Payable, Current for the quarter ending September 30, 2023 was $7.78M, a 21.9% decline year-over-year.
Accounts Payable, Current, Quarterly (USD)
Accounts Payable, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $7.78M -$2.18M -21.9% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $6.88M -$1.01M -12.8% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $12.5M +$3.31M +36.2% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $10.1M +$4.87M +93.9% Dec 31, 2022 6-K 2023-12-01
Q3 2022 $9.96M +$4.29M +75.7% Sep 30, 2022 6-K 2022-11-15
Q2 2022 $7.88M +$3.33M +73.2% Jun 30, 2022 6-K 2022-08-09
Q1 2022 $9.14M +$3.61M +65.4% Mar 31, 2022 6-K 2022-05-10
Q4 2021 $5.19M -$2.91M -35.9% Dec 31, 2021 20-F 2023-04-04
Q3 2021 $5.67M Sep 30, 2021 6-K 2021-11-09
Q2 2021 $4.55M -$8.31M -64.6% Jun 30, 2021 6-K 2021-08-16
Q1 2021 $5.53M Mar 31, 2021 6-K 2021-05-17
Q4 2020 $8.09M +$2.28M +39.1% Dec 31, 2020 20-F 2022-03-31
Q2 2020 $12.9M Jun 30, 2020 6-K 2020-10-29
Q4 2019 $5.82M Dec 31, 2019 20-F 2021-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.